| |
|
|
|
|
|
| Dr. Robert FosterDr. Robert Foster founded the Company and has been an officer and director of the Company since 1993. read more ... |
| Dr. Launa AspesletDr. Aspeslet has been with the Company since 1996 and was appointed Chief Operating Officer in January 2006. read more ... |
| Dennis BourgeaultDennis Bourgeault has been the Chief Financial Officer of the Company since 1998 and is responsible for the financial operation of the Company. read more ... |
| Dr. Derrick FreitagDr. Derrick Freitag has been with Isotechnika since 1996 and prior to his appointment as Chief Scientific Officer in October 2007, Dr. Freitag held the position of Senior Director, Biopharmaceutics. read more ... |
| Robert HuizingaMr. Huizinga has been with the Company since 2002, and most recently served as Senior Director, Clinical Affairs, focused on managing the global clinical development of voclosporin. read more ... |
|
|
|
|
|
|
|
|
| Robert Foster - ChairmanDr. Robert Foster founded the Company and has been an officer and director of the Company since 1993. read more ... |
| Wooyoung ChoiMr. Wooyoung Choi is the General Counsel for ILJIN Group. He holds a Master of Arts degree in Political Science from the Graduate School read more ... |
| Prakash GowdPrakash Gowd has extensive experience in the healthcare and investment fields attained over the last twenty years. read more ... |
| Daniel ParkMr. Park is currently the Executive Vice President of ILJIN Group. read more ... |
| Peter WijngaardDr. Peter Wijngaard is the Vice President, Innovation Leader Research & Development for the Medicines Company (Schweiz) GmbH. read more ... |
| Donald WyattMr. Wyatt has over 20 years of experience in the pharmaceutical industry, including research and legal representation. read more ... |
| Heung-Joon YangHeung-Joon Yang was formerly President and CEO of LG Life Sciences Ltd. in Seoul, Korea. read more ... |
|
|
|
|
|
|
|
|